Join us in person!
We will warmly welcome you with breakfast.
Each participant in attendance will be given a gourmet boxed meal.
Gifts and a random draw of all tickets will be held for a chance at attending events in 2022 for free.
Experience this truly live event and meet the speakers.
Bring your colleagues or business contacts along.
Take advantage of our smart networking tool to make new business contacts.
Over the past two years, the COVID-19 crisis has shone a spotlight on the life sciences, and on pharmaceuticals in particular. This flourishing industry reminds us of the importance of research and innovation and their global impact.
The pharmaceutical industry is one of the most strategic sectors in our province and contributes directly to our growth and our prosperity. Let's take advantage of the collective awareness of the important role of the pharmaceutic industry in innovation and economic development and seize the opportunities now!
R&D in Quebec is facilitated by a large number of biotechnology and artificial intelligence companies, several universities that train a specialized workforce, recognized research centres, and a public health system that generates a large amount of data. All of this helps create a variety of partnerships that enhance the therapeutic expertise of health professionals, which has been demonstrated since the beginning of the pandemic.
In this context, it is essential to ensure that the industry has all the resources it needs to continue to be a growth vector for Québec and Greater Montréal. The regulatory framework must reflect the reality of the sector by being flexible and conducive to R&D. We must also continue to attract investment and major players by leveraging the strengths of the local ecosystem, while positioning Montréal as a key hub in the pharmaceutical field.
During this strategic forum, we will bring together stakeholders from the life sciences and health technologies sectors to take stock of the situation and to look at the following three themes:
- Seize innovation opportunities created by the pandemic
- Identify the growth levers for the life sciences sector in Greater Montréal
- Make Montréal an international life sciences hub
We're counting on you to be there, so register now!
Program:
7:30 a.m. Registration, coffee and networking
8:30 a.m. Welcoming remarks
Master of ceremonies
BLOCK 1 – SEIZE THE OPPORTUNITY PRESENTED BY THE PANDEMIC
8:35 a.m. Introduction
-
Michel LeblancPresident and CEO
Chamber of Commerce of Metropolitan Montreal
-
The Honourable François-Philippe Champagne Minister of Innovation, Science and Industry
-
Pierre Fitzgibbon Minister of Economy and Innovation
9:10 a.m. Presentation: The pharma sector, a flagship LSHT industry
9:15 a.m. Presentation: The situation of the LSHT industry
9:25 a.m. Presentation: Overview of the pharmaceutical sector in Montréal: A high value-added sector
9 h 35 : The successes of the Montreal pharmaceutical industry
-
Dr Jean-Claude Tardif Director, Research Center, Montreal Heart Institute
Scientific Director, Montreal Health Innovations Coordinating Centre (MHICC)
Professor, Faculty of Medicine, Université de Montréal
9:45 a.m. Panel: A new era of collaboration in the pharmaceutical ecosystem
-
Carole Jabet Scientific Director
Fonds de recherche du Québec – Santé (FRQS)
-
Diane Gosselin, Ph. D., MBA, ASC President and CEO
CQDM
-
Michel Bouvier Chief Executive Officer and Principal Investigator, IRIC
Professor, Faculty of Medicine, Université de Montréal
-
Patrice Roy, Ph. D., MBA Team Lead
Medical Affairs, Inflammation and Immunology
Pfizer Canada
Moderator:
10:15 a.m. Joint presentation – A concrete case: The new Center of Expertise in Diabetes at CHUM
-
Kathy Malas Innovation & Artificial Intelligence Lead,
Office of the Chief Executive Officer, CHUM,
Associate professor, HEC Montréal
CHUM Research Centre
-
Benoit Tousignant Senior Manager, External Affairs
Novo Nordisk Canada Inc.
10:30 a.m. Networking break
BLOCK 2 – IDENTIFYING GROWTH LEVERS FOR GREATER MONTRÉAL'S PHARMACEUTICAL SECTOR
10:55 a.m. Panel: Ensuring an environment conducive to the development of new pharmaceutical treatments
-
Paul Lévesque President and CEO
Theratechnologies Inc.
-
Stéphanie Lord-Fontaine, Ph. D. Vice President, Scientific Affairs
Génome Québec
-
Dr. Youssef Bennani Managing Partner, Fund III
CTI Life Sciences Fund
Moderator:
11: 20 a.m. Panel: Better integrating innovations into the healthcare system
-
Paul L'Archevêque Head of Innovation in Health and Social Services
Innovation Office
Ministère de la Santé et des Services sociaux
-
Frédéric Alberro Executive Director
Innovative Medicines Canada
-
Anie Perrault, LL. L, ASCExecutive Director
BIOQuébec
Moderator:
11:50 a.m. Panel: Increasing local production capacity
-
Yves Joanette, Ph. D. FCAHS Associate Vice-Principal, Research
Université de Montréal
-
Nawel Rojkjaer Founder President
SmokePond Biologics
Moderator:
BLOCK 3 – MAKING MONTRÉAL AN INTERNATIONAL LSHT HUB
12:10 p.m. Presentation: Innovation zones as an attraction factor
12:20 p.m. Presentation: The coolest hotspot – Quebec's Life Sciences & Health Tech
12:25 a.m. Panel: Leveraging our niches of excellence
-
Nadine Beauger President and Chief Executive Officer
IRICoR
-
Stéphane Létourneau Executive Vice President
Mila
-
Stéphane Paquet President and Chief Executive Officer
Montréal International
Moderator:
12:55 p.m. Closing remarks
1:00 p.m. Lunch and networking
2:00 p.m. End of the Forum
The CCMM is ready to welcome members of the business community back to its in-person events, providing a safe environment that complies with all current health requirements.
All necessary measures are being taken to stop the spread of COVID-19 and ensure the health and safety of our participants, guests and employees.
As of September 1, the CCMM will require a vaccination passport and proof of identity from everyone who wants to access its in-person events.
All the information about the health instructions and agenda will be sent to registered participants a few days before the event.
For more information, visit our FAQ.